Friday 13 December 2019 ,
Friday 13 December 2019 ,
Latest News
  • Govt has nothing to do with Khaleda’s case: Quader
  • Suu Kyi slammed for ‘silence’ over Myanmar genocide claims
  • Police arrest protesters amid curfew in India's northeast
  • Be alert against bribery, corruption: PM
  • FM’s Delhi visit cancelled for ‘busy schedule’ at home
3 December, 2019 11:00:38 AM / LAST MODIFIED: 3 December, 2019 12:59:26 PM
Print

Pharma raw materials to be produced locally in 4 years

When Bangladesh becomes a mid-income country by 2024, it may lose existing facilities under TRIPS
Staff Reporter, Back from Munshiganj
Pharma raw materials to be produced locally in 4 years

Nazmul Hassan, president of the Association of Pharmaceutical Industries, yesterday said that the production of active pharmaceutical ingredients (API) for the pharmaceutical industry would begin at Gazaria, Munshiganj, in 2023. He said this while inaugurating the construction work of the common effluent treatment plant (CETP) in the plant area of the industrial park. Md Mostaque Hassan, chairman of the Bangladesh Small and Cottage Industries Corporation (BSCIC), said that the work on upgrading the park would be completed by June next year.

Nazmul Hasan, who is also a lawmaker, said that Bangladesh, as an LDC, would not have to pay any royalty for producing patented drugs till 2033, thus getting a great opportunity to produce API for its own use.

“Our country will turn into a developing country in 2024. So, it's high time we made our own API plant before that. If we make it by then, we will not have to pay the patent royalty. After 2024, when Bangladesh becomes a middle-income country, it may lose the existing facilities under TRIPS (Trade-Related Aspects of Intellectual Property Rights) agreement. So, we must be prepared by that time,” he said.

"Bangladesh imports API from India and China, but they suddenly stopped exporting raw materials. As a result, the cost of medicine is increasing,” explained Papon.

He said Bangladesh should end its dependence on other countries for API. India and China are competing to grab the global pharmaceutical market, he added

Despite the adverse effects of affected API imports, drug prices are stable in the country, said Nazmul Hasan. He, however, warned that it would not remain so if the prices of raw materials continued to rise.

Nazmul Hasan, who is also the managing director of Beximco Pharmaceuticals, observed that Bangladesh would become a major global hub for high-quality, low-cost generic medicines and vaccines.

India and China are losing cost advantages, he pointed out. Papon also said that one of

the major challenges before the country’s medicine sector was a high dependence on raw material imports, hampering competitiveness in the global market. The country can save at least 70 per cent of the import cost of raw materials by producing API, he added. To reap the benefits, Bangladesh would have to develop the knowledge and capacity to grab a bigger share of the global pharmaceutical market, he noted.

Maj. Gen. Dr Mahabubur Rahman, director general of the Directorate of Drug Administration, Md Mostaque Hassan, chairman of BSCIC, and Alla Ayodhya Rami Reddy, chairman of Ramky Group in India, were also present at the programme.

According to the BSCIC chairman, the first phase of the plant construction would be completed in the next 15 months. After 21 months, the entire project would be completed. The plant would have the capacity to purify 2 million litres of water daily, he said.

In order to protect the environment, these world-class waste treatment plants would be readied in advance. The Ramky Group would work on the waste refinery.

As much as 20 per cent water would be will be used here. The remaining 75 per cent of the water will be used in daily life. The pharmaceutical industry park construction project was approved on 200 acres of land in Gazaria, Munshiganj. The estimated expenditure was Tk. 212 crore in 2008. Since it was not implemented within the stipulated time, the cost has now increased to Tk. 381 crore. Of that, 20 per cent, equalling Tk. 80 crore, would be paid by pharmaceutical industry owners.

There are 42 plots in this industrial park. Entrepreneurs will have to pay Tk. 3 crore 5 lakh per acre of land.

NS

 

 

Comments

Video
More Bangladesh Stories
Keraniganj fire death toll hits 13 The death toll in the fire at the Prime Patent Plastic Limited factory in Keraniganj rose to 13 after an injured died at the Dhaka Medical College Hospital (DMCH) yesterday. Around 5pm on Wednesday, a fire ravaged the plastic factory,…

Copyright © All right reserved.

Editor : M. Shamsur Rahman

Published by the Editor on behalf of Independent Publications Limited at Media Printers, 446/H, Tejgaon I/A, Dhaka-1215.
Editorial, News & Commercial Offices : Beximco Media Complex, 149-150 Tejgaon I/A, Dhaka-1208, Bangladesh. GPO Box No. 934, Dhaka-1000.

Editor : M. Shamsur Rahman
Published by the Editor on behalf of Independent Publications Limited at Media Printers, 446/H, Tejgaon I/A, Dhaka-1215.
Editorial, News & Commercial Offices : Beximco Media Complex, 149-150 Tejgaon I/A, Dhaka-1208, Bangladesh. GPO Box No. 934, Dhaka-1000.

Disclaimer & Privacy Policy
....................................................
About Us
....................................................
Contact Us
....................................................
Advertisement
....................................................
Subscription

Powered by : Frog Hosting